Sports

Pfizer asks US officials to OK promising COVID-19 pill

Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.

Improper Payments Fact Sheet

Improper payments represent payments that do not meet program requirements. The vast majority of improper payments occur in regards to people who may be eligible for care, but for whom there was an unintentional payment error or a reviewer cannot determine if a payment was proper due to insufficient payment documentation from a state or a provider.

FDA considers boosters for all adults amid threat of winter surger

When the Supreme Court ended the Biden administration’s eviction moratorium in late August, some advocates expected a flash flood of evictions. Instead, it’s been more like a slow-moving mudslide, reports Sophie Kasakove in The New York Times.

New Program Reduces Healthcare Barriers in the Inland Empire

This fall Inland Empire Health Plan (IEHP) is partnering with Loma Linda University (LLU) and community agencies to train, place and support community health workers (CHWs) in the Inland Empire (I.E.).  The pilot program is aimed at reducing barriers to health care services in marginalized and underserved areas and encouraging diversity, equity and inclusion (DEI).

Coverage is Available for COVID-19 Vaccinations for Eligible Children Ages 5 through 11

Following the U.S. Food & Drug Administration’s (FDA) recent action authorizing the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in children 5 through 11 years of age and a recommendation from the Centers for Disease Control and Prevention (CDC), the Centers for Medicare & Medicaid Services (CMS) is reminding eligible consumers that coverage is available without cost-sharing under Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and in the commercial market for this critical protection from the virus. As with all vaccines, the Pfizer-BioNTech COVID-19 Vaccine was tested thoroughly in this age group prior to its authorization for emergency use.

Popular